Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,001 JPY | +0.05% | -0.89% | -7.83% |
2023 | HABA Laboratories,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
2021 | HABA Laboratories,Inc.(JASDAQ:4925) dropped from S&P Global BMI Index | CI |
Sales 2022 | 12.91B 84.34M | Sales 2023 | 12.04B 78.66M | Capitalization | 8.81B 57.57M |
---|---|---|---|---|---|
Net income 2022 | -269M -1.76M | Net income 2023 | -707M -4.62M | EV / Sales 2022 | 0.39 x |
Net cash position 2022 | 3.09B 20.22M | Net cash position 2023 | 2.78B 18.2M | EV / Sales 2023 | 0.5 x |
P/E ratio 2022 |
-30.4
x | P/E ratio 2023 |
-12.5
x | Employees | 654 |
Yield 2022 |
1.85% | Yield 2023 |
1.72% | Free-Float | 56.05% |
1 day | +0.05% | ||
1 week | -0.89% | ||
Current month | -0.60% | ||
1 month | -3.29% | ||
3 months | -7.10% | ||
6 months | -13.68% | ||
Current year | -7.83% |
Managers | Title | Age | Since |
---|---|---|---|
Issei Miyazaki
CEO | Chief Executive Officer | 61 | 13-09-30 |
Noriko Koyanagi
CHM | Chairman | 78 | 15-05-31 |
Chief Tech/Sci/R&D Officer | 59 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tsunekazu Umeda
BRD | Director/Board Member | 78 | 00-05-31 |
Noriko Koyanagi
CHM | Chairman | 78 | 15-05-31 |
Issei Miyazaki
CEO | Chief Executive Officer | 61 | 13-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 2,001 | +0.05% | 4,100 |
24-05-01 | 2,000 | -0.65% | 8,800 |
24-04-30 | 2,013 | -0.10% | 1,600 |
24-04-26 | 2,015 | -0.20% | 1,200 |
24-04-25 | 2,019 | +0.15% | 1,800 |
Delayed Quote Japan Exchange, May 02, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-7.83% | 49.2M | |
-2.16% | 250B | |
+12.81% | 19.77B | |
0.00% | 17.89B | |
+0.38% | 11.09B | |
+16.34% | 7.75B | |
+10.15% | 5.97B | |
+1.12% | 4.52B | |
-17.29% | 3.8B | |
-5.56% | 3.45B |
- Stock Market
- Equities
- 4925 Stock